Isolation and characterization of runxa and runxb, zebrafish members of the runt family of transcriptional regulators

Experimental Hematology

Volumn 30, Issue 12, 2002, Pages 1381-1389

  Burns, Caroline Erter ^b   DeBlasio, Tony ^a   Zhou, Yi ^b   Zhang, Jin ^a   Zon, Leonard ^b   Nimer, Stephen D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER; COMPLEMENTARY DNA; PROTEIN; PROTEIN RUNXA; PROTEIN RUNXB; TRANSCRIPTION FACTOR RUNX1; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

AORTA; ARTICLE; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; FERTILIZATION; GENOMICS; HEMATOPOIETIC CELL; HEMATOPOIETIC SYSTEM; HUMAN; IN SITU HYBRIDIZATION; MESODERM; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN ISOLATION; TRANSCRIPTION REGULATION; ZEBRA FISH;

AMINO ACID SEQUENCE; ANIMALS; AORTA; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CORE BINDING FACTOR ALPHA 3 SUBUNIT; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; EMBRYO, NONMAMMALIAN; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GONADS; HEMATOPOIESIS; HUMANS; LINKAGE (GENETICS); MESONEPHROS; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSCRIPTION FACTORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

DANIO RERIO; MURINAE; VERTEBRATA;

EID: 0036899190     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00955-4     Document Type: Article

References (60)

1. Tracey W.D., Speck N.A. Potential roles for RUNX1 and its orthologs in determining hematopoietic cell fate. Semin Cell Dev Biol. 11:2000;337.
2. Canon J., Banerjee U. Runt and Lozenge function in Drosophila development. Semin Cell Dev Biol. 11:2000;327.
3. Gergen J.P., Wieschaus E.F. The localized requirements for a gene affecting segmentation in Drosophila. analysis of larvae mosaic for runt Dev Biol. 109:1985;321.
4. Levanon D., Bernstein Y., Negreanu V.et al. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1. DNA Cell Biol. 15:1996;175.
5. Levanon D., Glusman G., Bangsow T.et al. Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1. Gene. 262:2001;23.
6. Miyoshi H., Ohira M., Shimizu K.et al. Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia. Nucleic Acids Res. 23:1995;2762.
7. Tanaka T., Tanaka K., Ogawa S.et al. An acute myeloid leukemia gene, AML1, regulates transcriptional activation and hemopoietic myeloid cell differentiation antagonistically by two alternative spliced forms. Leukemia. 11(suppl 3):1997;299.
8. Tighe J.E., Calabi F. Alternative, out-of-frame runt/MTG8 transcripts are encoded by the derivative (8) chromosome in the t(8;21) of acute myeloid leukemia M2. Blood. 84:1994;2115.
9. Fenrick R., Amann J.M., Lutterbach B.et al. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein. Mol Cell Biol. 19:1999;6566.
10. Lutterbach B., Westendorf J.J., Linggi B., Isaac S., Seto E., Hiebert S.W. A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia. J Biol Chem. 275:2000;651.
11. Levanon D., Goldstein R.E., Bernstein Y.et al. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors. Proc Natl Acad Sci U S A. 95:1998;11590.
12. Meyers S., Downing J.R., Hiebert S.W. Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins. the runt homology domain is required for DNA binding and protein-protein interactions Mol Cell Biol. 13:1993;6336.
13. Nagata T., Gupta V., Sorce D.et al. Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain. Nat Struct Biol. 6:1999;615.
14. Adya N., Castilla L.H., Liu P.P. Function of CBFβ/Bro proteins. Semin Cell Dev Biol. 11:2000;361.
15. Golling G., Li L., Pepling M., Stebbins M., Gergen J.P. Drosophila homologs of the proto-oncogene product PEBP2/CBF β regulate the DNA-binding properties of Runt. Mol Cell Biol. 16:1996;932.
16. Li L.H., Gergen J.P. Differential interactions between Brother proteins and Runt domain proteins in the Drosophila embryo and eye. Development. 126:1999;3313.
17. Kagoshima H., Akamatsu Y., Ito Y., Shigesada K. Functional dissection of the α and β subunits of transcription factor PEBP2 and the redox susceptibility of its DNA binding activity. J Biol Chem. 271:1996;33074.
18. Jakubowiak A., Pouponnot C., Berguido F.et al. Inhibition of the transforming growth factor β 1 signaling pathway by the AML1/ETO leukemia-associated fusion protein. J Biol Chem. 275:2000;40282.
19. Mao S., Frank R.C., Zhang J., Miyazaki Y., Nimer S.D. Functional and physical interactions between AML1 proteins and an ETS protein, MEF. implications for the pathogenesis of t(8;21)-positive leukemias Mol Cell Biol. 19:1999;3635.
20. Westendorf J.J., Yamamoto C.M., Lenny N., Downing J.R., Selsted M.E., Hiebert S.W. The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-α, inhibits C/EBP-α-dependent transcription, and blocks granulocytic differentiation. Mol Cell Biol. 18:1998;322.
21. Bruhn L., Munnerlyn A., Grosschedl R. ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRα enhancer function. Genes Dev. 11:1997;640.
22. Kitabayashi I., Yokoyama A., Shimizu K., Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J. 17:1998;2994.
23. Okuda T., van Deursen J., Hiebert S.W., Grosveld G., Downing J.R. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell. 84:1996;321.
24. Wang Q., Stacy T., Binder M., Marin-Padilla M., Sharpe A.H., Speck N.A. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Natl Acad Sci U S A. 93:1996;3444.
25. Okuda T., Nishimura M., Nakao M., Fujita Y. RUNX1/AML1. a central player in hematopoiesis Int J Hematol. 74:2001;252.
26. Fujita Y., Nishimura M., Taniwaki M., Abe T., Okuda T. Identification of an alternatively spliced form of the mouse AML1/RUNX1 gene transcript AML1c and its expression in early hematopoietic development. Biochem Biophys Res Commun. 281:2001;1248.
27. Telfer J.C., Rothenberg E.V. Expression and function of a stem cell promoter for the murine CBFα2 gene. distinct roles and regulation in natural killer and T cell development Dev Biol. 229:2001;363.
28. Era T., Asou N., Kunisada T.et al. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells. Genes Chromosomes Cancer. 13:1995;25.
29. Lebestky T., Chang T., Hartenstein V., Banerjee U. Specification of Drosophila hematopoietic lineage by conserved transcription factors. Science. 288:2000;146.
30. Tracey W.D. Jr., Pepling M.E., Horb M.E., Thomsen G.H., Gergen J.P. A Xenopus homologue of aml-1 reveals unexpected patterning mechanisms leading to the formation of embryonic blood. Development. 125:1998;1371.
31. Look A.T. Oncogenic transcription factors in the human acute leukemias. Science. 278:1997;1059.
32. Song W.J., Sullivan M.G., Legare R.D.et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukemia. Nat Genet. 23:1999;166.
33. Komori T., Yagi H., Nomura S.et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell. 89:1997;755.
34. Otto F., Thornell A.P., Crompton T.et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell. 89:1997;765.
35. Lee B., Thirunavukkarasu K., Zhou L.et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nat Genet. 16:1997;307.
36. Mundlos S., Otto F., Mundlos C.et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell. 89:1997;773.
37. Li Q.L., Ito K., Sakakura C.et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell. 109:2002;113.
38. Le X.F., Groner Y., Kornblau S.M.et al. Regulation of AML2/CBFA3 in hematopoietic cells through the retinoic acid receptor α-dependent signaling pathway. J Biol Chem. 274:1999;21651.
39. Meyers S., Lenny N., Sun W., Hiebert S.W. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia. Oncogene. 13:1996;303.
40. Kalev-Zylinska M.L., Horsfield J.A., Flores M.V.et al. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development. 129:2002;2015.
41. Kataoka H., Ochi M., Enomoto K., Yamaguchi A. Cloning and embryonic expression patterns of the zebrafish Runt domain genes, runxa and runxb. Mech Dev. 98:2000;139.
42. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156.
43. Stainier D.Y., Weinstein B.M., Detrich H.W. 3rd, Zon L.I., Fishman M.C. Cloche, an early acting zebrafish gene, is required by both the endothelial and hematopoietic lineages. Development. 121:1995;3141.
44. Westerfield M (1995) The Zebrafish Book. Eugene, Oregon: Eugene Press.
45. Thisse C, Thisse B, Schilling TF, Postlethwait JH (1993) Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. Development 119:1203.
46. Seed B., Sheen J.Y. A simple phase-extraction assay for chloramphenicol acyltransferase activity. Gene. 67:1988;271.
47. Geisler R., Rauch G.J., Baier H.et al. A radiation hybrid map of the zebrafish genome. Nat Genet. 23:1999;86.
48. Hukriede N.A., Joly L., Tsang M.et al. Radiation hybrid mapping of the zebrafish genome. Proc Natl Acad Sci U S A. 96:1999;9745.
49. Kozak M. At least six nucleotides preceding the AUG initiator codon enhance translation in mammalian cells. J Mol Biol. 196:1987;947.
50. Akamatsu Y., Ohno T., Hirota K., Kagoshima H., Yodoi J., Shigesada K. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues. J Biol Chem. 272:1997;14497.
51. Frank R., Zhang J., Uchida H., Meyers S., Hiebert S.W., Nimer S.D. The AML1/ETO fusion protein blocks transactivation of the GM-CSF promoter by AML1B. Oncogene. 11:1995;2667.
52. Uchida H., Zhang J., Nimer S.D. AML1A and AML1B can transactivate the human IL-3 promoter. J Immunol. 158:1997;2251.
53. Simeone A., Daga A., Calabi F. Expression of runt in the mouse embryo. Dev Dyn. 203:1995;61.
54. North T., Gu T.L., Stacy T.et al. Cbfa2 is required for the formation of intra-aortic hematopoietic clusters. Development. 126:1999;2563.
55. Ciau-Uitz A., Walmsley M., Patient R. Distinct origins of adult and embryonic blood in Xenopus. Cell. 102:2000;787.
56. Levanon D., Brenner O., Negreanu V.et al. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates nonredundant functions during mouse embryogenesis. Mech Dev. 109:2001;413.
57. Blake T., Adya N., Kim C.H.et al. Zebrafish homolog of the leukemia gene CBFB. its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis Blood. 96:2000;4178.
58. Rodan G.A., Harada S. The missing bone. Cell. 89:1997;677.
59. Bangsow C., Rubins N., Glusman G.et al. The RUNX3 gene - sequence, structure and regulated expression. Gene. 279:2001;221.
60. Ghozi M.C., Bernstein Y., Negreanu V., Levanon D., Groner Y. Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions. Proc Natl Acad Sci U S A. 93:1996;1935.